HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Louise Cullen Selected Research

Chest Pain (Chest Pains)

12/2015The utility of presentation and 4-hour high sensitivity troponin I to rule-out acute myocardial infarction in the emergency department.
10/2015'Chest pain typicality' in suspected acute coronary syndromes and the impact of clinical experience.
5/2015Two-hour diagnostic algorithms for early assessment of patients with acute chest pain--Implications of lowering the cardiac troponin I cut-off to the 97.5th percentile.
4/2015Accelerated diagnostic protocol using high-sensitivity cardiac troponin T in acute chest pain patients.
11/2014Comparison of new point-of-care troponin assay with high sensitivity troponin in diagnosing myocardial infarction.
4/2014Comparison of high sensitivity troponin T and I assays in the diagnosis of non-ST elevation acute myocardial infarction in emergency patients with chest pain.
4/2014Limited utility of exercise stress testing in the evaluation of suspected acute coronary syndrome in patients aged less than 40 years with intermediate risk features.
3/2014Implementation of a chest pain management service improves patient care and reduces length of stay.
2/2014Validation of an accelerated high-sensitivity troponin T assay protocol in an Australian cohort with chest pain.
2/2014Development and validation of the Emergency Department Assessment of Chest pain Score and 2 h accelerated diagnostic protocol.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Louise Cullen Research Topics

Disease

24Chest Pain (Chest Pains)
12/2015 - 03/2011
21Myocardial Infarction
12/2015 - 03/2011
15Acute Coronary Syndrome
10/2015 - 03/2011
3Pain (Aches)
02/2014 - 07/2013
2Infection
10/2015 - 01/2015
2Hypertension (High Blood Pressure)
08/2015 - 07/2013
2Myocardial Ischemia (Ischemic Heart Diseases)
10/2012 - 06/2011
1Coronary Artery Disease (Coronary Atherosclerosis)
10/2015
1Ischemia
07/2015
1Atrioventricular Block
05/2015
1Pulmonary Embolism
05/2015
1Necrosis
10/2013
1Coronary Disease (Coronary Heart Disease)
07/2013
1Dyslipidemias (Dyslipidemia)
07/2013
1Heart Diseases (Heart Disease)
07/2013
1Kidney Diseases (Kidney Disease)
07/2013
1Heart Failure
03/2012
1Epistaxis (Nosebleed)
08/2004

Drug/Important Bio-Agent (IBA)

23TroponinIBA
12/2015 - 03/2011
8Troponin T (T, Troponin)IBA
07/2015 - 08/2011
7Adenosine Diphosphate (ADP)IBA
07/2015 - 03/2011
4Troponin IIBA
12/2015 - 06/2012
4trans-crotonin (CTN)IBA
10/2015 - 10/2013
3Biological Markers (Surrogate Marker)IBA
04/2014 - 10/2012
2omega-Chloroacetophenone (Mace)IBA
11/2014 - 09/2013
2MB Form Creatine KinaseIBA
10/2012 - 03/2011
2MyoglobinIBA
10/2012 - 03/2011
1alginic acid (sodium alginate)IBA
10/2015
1UreaseIBA
10/2015
1PyocyanineIBA
10/2015
1O Antigens (O Antigen)IBA
10/2015
1Virulence Factors (Pathogenicity Factors)IBA
01/2015
1CreatinineIBA
07/2013
1Lidocaine (Xylocaine)FDA LinkGeneric
08/2004

Therapy/Procedure

4Length of Stay
05/2015 - 06/2011
1Ambulatory Care (Outpatient Care)
10/2012